GEN Exclusives

More »

GEN News Highlights

More »
May 21, 2014

Tel Aviv, Tsinghua Universities Establish $300M Research Center

  • Tel Aviv University (TAU) and Beijing's Tsinghua University have inaugurated a new research center, dubbed the XIN Center, dedicated to training scientific innovators ("XIN Fellows") from both Israel and China and focused on areas including nanotechnology, renewable energy, and biotech. The two universities plan to invest $300 million jointly into the XIN Center over the next five years.

    The seeds for the XIN Center were planted back in September, when TAU president Joseph Klafter, Ph.D., and Tsinghua University president Chen Jining, Ph.D., signed an MOU in Beijing to establish a joint center of excellence named XIN ("new" in Chinese). The main complex of the XIN center will be on the Tsinghua University campus; a smaller sister facility at Tel-Aviv University wil also be established. Research at XIN will initially focus on nanoscience and nanotechnology. 

    TAU and Tsinghua, along with the MOU, also announced in September plans to establish a 100 million yuan (around $16 million) investment fund to seed ventures initiated by XIN Fellows. This fund, they said, will be set up by Infinity Group, and investors will include Tsinghua alumni and the Beijing government.

    The two universities hope XIN, in addition to nurturing creativity among students and researchers and expanding cooperation between academia and the industry, will enhance the Chinese-Israeli contribution to scientific and technological progress worldwide and also create an international hub for innovation.

    At XIN's inauguration ceremony, Dr. Klafter noted that XIN is the largest joint research and teaching project to be established between Israel and China. "In founding the XIN Center, we are building an interconnected future, one full of infinite possibilities and that is firmly anchored in shared values," he added.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »